ApicHope Pharmaceutical Co., Ltd. (300723) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

ApicHope Pharmaceutical Co., Ltd.

Why is ApicHope Pharmaceutical Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -5.93% and Operating profit at -230.00% over the last 5 years

The company has declared Negative results for the last 7 consecutive quarters

OPERATING CASH FLOW(Y) Lowest at CNY -558.24 MM
NET SALES(Q) At CNY 372.85 MM has Fallen at -39.41%
ROCE(HY) Lowest at -25.63%

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 202.54%, its profits have fallen by -15480.9%
At the current price, the company has a high dividend yield of 0

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is ApicHope Pharmaceutical Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

ApicHope Pharmaceutical Co., Ltd.

161.07%

1.48

82.63%

China Shanghai Composite

15.19%

1.01

15.10%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-5.93%

EBIT Growth (5y)

-230.00%

EBIT to Interest (avg)

7.32

Debt to EBITDA (avg)

1.10

Net Debt to Equity (avg)

0.87

Sales to Capital Employed (avg)

0.54

Tax Ratio

12.64%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

8.68%

ROE (avg)

9.84%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

13.76

EV to EBIT

-50.79

EV to EBITDA

-95.27

EV to Capital Employed

8.03

EV to Sales

23.98

PEG Ratio

Dividend Yield

ROCE (Latest)

-15.81%

ROE (Latest)

-36.86%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company

NET PROFIT(HY)

Higher at CNY -229.82 MM

-37What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY -558.24 MM

NET SALES(Q)

At CNY 372.85 MM has Fallen at -39.41%

ROCE(HY)

Lowest at -25.63%

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.31%

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.63%

PRE-TAX PROFIT(Q)

At CNY 60.12 MM has Fallen at -46.17%

NET PROFIT(Q)

At CNY 56.59 MM has Fallen at -43.7%

RAW MATERIAL COST(Y)

Grown by 14.29% (YoY

DEBT-EQUITY RATIO (HY)

Highest at 87.28 %

INTEREST(Q)

Highest at CNY 16.58 MM

Here's what is not working for ApicHope Pharmaceutical Co., Ltd.

Net Sales

At CNY 372.85 MM has Fallen at -39.41%

Year on Year (YoY)

MOJO Watch

Near term sales trend is extremely negative

Net Sales (CNY MM)

Operating Cash Flow

Lowest at CNY -558.24 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Interest

At CNY 16.58 MM has Grown at 72.92%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Pre-Tax Profit

At CNY 60.12 MM has Fallen at -46.17%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 56.59 MM has Fallen at -43.7%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Inventory Turnover Ratio

Lowest at 2.31% and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio

Lowest at 2.63% and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Interest

Highest at CNY 16.58 MM

in the last five periods and Increased by 72.92% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Debt-Equity Ratio

Highest at 87.28 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Raw Material Cost

Grown by 14.29% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales